399 related articles for article (PubMed ID: 23351639)
21. Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours.
Santos A; Lopes C; Marques RM; Amorim I; Ribeiro J; Frias C; Vicente C; Gärtner F; de Matos A
Vet J; 2011 Jul; 189(1):43-8. PubMed ID: 20598596
[TBL] [Abstract][Full Text] [Related]
22. Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer.
Alonso-Diez A; Affolter VK; Sevane N; Dunner S; Valdivia G; Clemente M; De Andrés PJ; Illera JC; Pérez-Alenza MD; Peña L
Res Vet Sci; 2022 Dec; 152():307-313. PubMed ID: 36084372
[TBL] [Abstract][Full Text] [Related]
23. Positive correlation of steroid hormones and EGF in canine mammary cancer.
Queiroga FL; Pérez-Alenza D; Silvan G; Peña L; Illera JC
J Steroid Biochem Mol Biol; 2009 May; 115(1-2):9-13. PubMed ID: 19429455
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
[TBL] [Abstract][Full Text] [Related]
25. Steroid Tumor Environment in Male and Female Mice Model of Canine and Human Inflammatory Breast Cancer.
Caceres S; Peña L; Silvan G; Illera MJ; Woodward WA; Reuben JM; Illera JC
Biomed Res Int; 2016; 2016():8909878. PubMed ID: 27195300
[TBL] [Abstract][Full Text] [Related]
26. Mammary cancer in the dog: a study of 120 cases.
Mulligan RM
Am J Vet Res; 1975 Sep; 36(9):1391-6. PubMed ID: 169716
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-8 expression associated with canine mammary tumors.
Zuccari DA; Castro R; Gelaleti GB; Mancini UM
Genet Mol Res; 2011; 10(3):1522-32. PubMed ID: 21863548
[TBL] [Abstract][Full Text] [Related]
28. [The levels of selected cytokines in patients with colorectal cancer--a preliminary report].
Grotowski M; Piechota W
Pol Merkur Lekarski; 2001 Oct; 11(64):327-9. PubMed ID: 11770312
[TBL] [Abstract][Full Text] [Related]
29. Markers of lipid peroxidation and α-tocopherol levels in the blood and neoplastic tissue of dogs with malignant mammary gland tumors.
Karayannopoulou M; Fytianou A; Assaloumidis N; Psalla D; Constantinidis TC; Kaldrymidou E; Koutinas AF
Vet Clin Pathol; 2013 Sep; 42(3):323-8. PubMed ID: 23906434
[TBL] [Abstract][Full Text] [Related]
30. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.
Queiroga FL; Perez-Alenza MD; González-Gil A; Silván G; Peña L; Illera JC
Vet Comp Oncol; 2017 Jun; 15(2):383-390. PubMed ID: 26463704
[TBL] [Abstract][Full Text] [Related]
31. Vasculogenic mimicry-associated ultrastructural findings in human and canine inflammatory breast cancer cell lines.
Barreno L; Cáceres S; Alonso-Diez Á; Vicente-Montaña A; García ML; Clemente M; Illera JC; Peña L
BMC Cancer; 2019 Jul; 19(1):750. PubMed ID: 31362745
[TBL] [Abstract][Full Text] [Related]
32. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
Ferreira E; Gobbi H; Saraiva BS; Cassali GD
Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA
J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366.
Caceres S; Peña L; de Andres PJ; Illera MJ; Lopez MS; Woodward WA; Reuben JM; Illera JC
PLoS One; 2015; 10(3):e0122277. PubMed ID: 25807360
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
[TBL] [Abstract][Full Text] [Related]
36. Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118.
Gao H; Zhou H; Gao Y; He L; Li W; Xu M; Feng H; Feng X; Qiu C
Vet Comp Oncol; 2022 Sep; 20(3):679-687. PubMed ID: 35429113
[TBL] [Abstract][Full Text] [Related]
37. Plasma interleukin-1α and interleukin-8 in female dogs with non-metastatic and metastatic malignant mammary gland tumours.
Szczubiał M; Łopuszyński W; Dąbrowski R; Bochniarz M; Brodzki P
Pol J Vet Sci; 2022 Jun; 25(2):317-324. PubMed ID: 35861995
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous canine mammary tumors. A model for monoclonal antibody diagnosis and treatment of human breast cancer.
Mottolese M; Morelli L; Agrimi U; Benevolo M; Sciarretta F; Antonucci G; Natali PG
Lab Invest; 1994 Aug; 71(2):182-7. PubMed ID: 8078297
[TBL] [Abstract][Full Text] [Related]
39. Expression and significance of IL-6 and IL-8 in canine mammary gland tumors.
Ren X; Fan Y; Shi D; Liu Y
Sci Rep; 2023 Jan; 13(1):1302. PubMed ID: 36693957
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress and inflammatory response biomarkers in dogs with mammary carcinoma.
Machado VS; Crivellenti LZ; Bottari NB; Tonin AA; Pelinson LP; Borin-Crivellenti S; Santana AE; Torbitz VD; Moresco RN; Duarte T; Duarte MM; Schetinger MR; Morsch VM; Jaques JA; Tinucci-Costa M; Da Silva AS
Pathol Res Pract; 2015 Sep; 211(9):677-81. PubMed ID: 26166177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]